Advanced search
Publication Cover
Current Medical Research and Opinion Volume 20, 2004 - Issue 5
Submit an article Journal homepage
90
Views
47
CrossRef citations to date
0
Altmetric
Research Article

Effect of atorvastatin on highdensity lipoprotein cholesteroland its relationship withcoronary events: a subgroupanalysis of the GREekAtorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

Dr Vasilios G. Athyros Atherosclerosis Unit, Aristotelian University, Hippocration Hospital, Thessaloniki, GreeceCorrespondence[email protected]
,
Dimitri P. Mikhailidis Department of Clinical Biochemistry, Royal Free Hospital and Royal Free and University College Medical School, London, UK
,
Athanasios A. Papageorgiou 2nd Propedeutic Department of Internal Medicine, Aristotelian University, Hippocration Hospital, Thessaloniki, 54642, Greece
,
Athanasios N. Symeonidis Greek Society of General Practitioners, Thessaloniki, Greece
,
Bodosakis R. Mercouris Greek Society of General Practitioners, Thessaloniki, Greece
,
Anthimos N. Pehlivanidis Atherosclerosis Unit, Aristotelian University, Hippocration Hospital, Thessaloniki, Greece
,
Vasilios I. Bouloukos Atherosclerosis Unit, Aristotelian University, Hippocration Hospital, Thessaloniki, Greece
,
Moses Elisaf Department of Internal Medicine, Medical School, University of Ioannina, Greece
& for the GREACE Study Collaborative Group show all
Pages 627-637 | Accepted 30 Jan 2004, Published online: 10 Mar 2004

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (15)

Vasilios G. Athyros, Konstantinos Tziomalos, Asterios Karagiannis & Dimitri P. Mikhailidis. (2015) Genetic, epidemiologic and clinical data strongly suggest that fasting or non-fasting triglycerides are independent cardiovascular risk factors. Current Medical Research and Opinion 31:3, pages 435-438.
Read now
Melissa E Stauffer, Lauren Weisenfluh & Alan Morrison. (2013) Association between triglycerides and cardiovascular events in primary populations: a meta-regression analysis and synthesis of evidence. Vascular Health and Risk Management 9, pages 671-680.
Read now
Kwadwo Osei Bonsu, Amudha Kadirvelu & Daniel Diamond Reidpath. (2013) Statins in heart failure: do we need another trial?. Vascular Health and Risk Management 9, pages 303-319.
Read now
Stephen J Nicholls, Kiyoko Uno, Yu Kataoka & Steven E Nissen. (2011) ETC-216 for coronary artery disease. Expert Opinion on Biological Therapy 11:3, pages 387-394.
Read now
Khalid Alwaili, Zuhier Awan, Ali Alshahrani & Jacques Genest. (2010) High-density lipoproteins and cardiovascular disease: 2010 update. Expert Review of Cardiovascular Therapy 8:3, pages 413-423.
Read now
Danny J Eapen, Girish L Kalra, Luay Rifai, Christina A Eapen, Nadya Merchant & Bobby V Khan. (2009) Raising HDL cholesterol in women. International Journal of Women's Health 1, pages 181-191.
Read now
MyNgan Duong & Stephen J Nicholls. (2009) Effect of lipid-modifying therapies on the functional quality of high-density lipoproteins: implications for drug development. Expert Opinion on Drug Discovery 4:7, pages 753-761.
Read now
J. Delgado Alves, E. Steinhagen-Thiessen, R. Darioli, U. Hostalek & A. Vogt. (2008) Influence of the timing of low-dose aspirin on tolerability of prolonged-release nicotinic acid in patients at elevated cardiovascular risk. Current Medical Research and Opinion 24:10, pages 2815-2820.
Read now
Jonathan Belsey, Simon de Lusignan, Tom Chan, Jeremy van Vlymen & Nigel Hague. (2008) Abnormal lipids in high-risk patients achieving cholesterol targets: a cross-sectional study of routinely collected UK general practice data. Current Medical Research and Opinion 24:9, pages 2551-2560.
Read now
Vasilios G. Athyros, Anna I. Kakafika, Athanasios A. Papageorgiou, Kosmas I. Paraskevas, Konstantinos Tziomalos, Panagiotis Anagnostis, Efstathios Pagourelias, Charalambos Koumaras, Asterios Karagiannis & Dimitri P. Mikhailidis. (2008) Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study. Current Medical Research and Opinion 24:6, pages 1593-1599.
Read now
Vasilios G Athyros, Anna Kakafika, Konstantinos Tziomalos, Asterios Karagiannis & Dimitri P Mikhailidis. (2008) Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?. Expert Opinion on Investigational Drugs 17:4, pages 445-449.
Read now
José V. Lozano, Vicente Pallarés, Luis Cea-Calvo, José L. Llisterri, Cristina Fernández-Pérez, Juan C. Martí-Canales, Jose Aznar, Vicente Gil-Guillén & Josep Redón. (2008) Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study. Current Medical Research and Opinion 24:3, pages 659-670.
Read now
Vasilios G Athyros, Konstantinos Tziomalos, Dimitri P Mikhailidis, Efstathios D Pagourelias, Anna I Kakafika, Athanasios Skaperdas, Apostolos Hatzitolios & Asterios Karagiannis. (2007) Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?. Expert Opinion on Pharmacotherapy 8:14, pages 2267-2277.
Read now
Konstantinos Tziomalos & Vasilios G Athyros. (2006) Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review. International Journal of Nanomedicine 1:2, pages 129-147.
Read now
Stella S. Daskalopoulou & Dimitri P. Mikhailidis. (2006) Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Current Medical Research and Opinion 22:3, pages 511-528.
Read now

Articles from other publishers (32)

Éva Máthéné Köteles, Beatrix Rafael, Andrea Korom, Anna Vágvölgyi, Judit Erzsébet Ábrahám, Andrea Domján, Mónika Szűcs, Attila Nemes, Mária Barnai, Csaba Lengyel & István Kósa. (2023) Physiological and psychological effects of a 12-week home-based telemonitored training in metabolic syndrome. Frontiers in Cardiovascular Medicine 9.
Crossref
Dagmara Sowińska, Alicja Pogorzelska, Marlena Rakicka, Justyna Sznura, Justyna Janowska, Patrycja Gorzycka, Mateusz Malak & Marta Karażniewicz-Łada. (2020) Development and Validation of an RP-HPLC Method for Determination of Atorvastatin and its Hydroxyl Metabolites in Human Plasma. Current Pharmaceutical Analysis 16:3, pages 238-245.
Crossref
Stephen J. Nicholls & Adam J. Nelson. (2019) HDL and cardiovascular disease. Pathology 51:2, pages 142-147.
Crossref
Sotirios K Karathanasis, Lita A Freeman, Scott M Gordon & Alan T Remaley. (2017) The Changing Face of HDL and the Best Way to Measure It. Clinical Chemistry 63:1, pages 196-210.
Crossref
Nitin Verma & Vincent M. Figueredo. (2014) HDL Cholesterol. American Journal of Therapeutics 21:3, pages 222-232.
Crossref
William E. Boden, Mandeep S. Sidhu & Peter P. Toth. (2013) The Therapeutic Role of Niacin in Dyslipidemia Management. Journal of Cardiovascular Pharmacology and Therapeutics 19:2, pages 141-158.
Crossref
Amirhossein Sahebkar. (2013) Fat lowers fat: Purified phospholipids as emerging therapies for dyslipidemia. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1831:4, pages 887-893.
Crossref
K Mahdy Ali, A Wonnerth, K Huber & J Wojta. (2012) Cardiovascular disease risk reduction by raising HDL cholesterol – current therapies and future opportunities. British Journal of Pharmacology 167:6, pages 1177-1194.
Crossref
Stephen J. Nicholls. (2012) Evacetrapib. Current Cardiology Reports 14:3, pages 245-250.
Crossref
Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis & Dimitri P. Mikhailidis. (2012) Should raising high-density lipoprotein cholesterol be a matter of debate?. Journal of Cardiovascular Medicine 13:4, pages 254-259.
Crossref
Stephen J. Nicholls, Allan Gordon, Jan Johannson, Christie M. Ballantyne, Philip J. Barter, H. Bryan Brewer, John J. P. Kastelein, Norman C. Wong, Marilyn R. N. Borgman & Steven E. Nissen. (2012) ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies. Cardiovascular Drugs and Therapy 26:2, pages 181-187.
Crossref
Stephen J. Nicholls. (2011) Apo A-I Modulating Therapies. Current Cardiology Reports 13:6, pages 537-543.
Crossref
A. V. Susekov & N. V. Khokhlova. (2011) Atorvastatin: evidence base 15 years later. Cardiovascular Therapy and Prevention 10:3, pages 103-112.
Crossref
Stephen J. Nicholls, Allan Gordon, Jan Johansson, Kathy Wolski, Christie M. Ballantyne, John J.P. Kastelein, Allen Taylor, Marilyn Borgman & Steven E. Nissen. (2011) Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease. Journal of the American College of Cardiology 57:9, pages 1111-1119.
Crossref
Stefania Lamon-Fava. 2010. High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease. High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease 151 155 .
Thomas F. WhayneJrJr. (2009) High-density Lipoprotein Cholesterol: Current Perspective for Clinicians. Angiology 60:5, pages 644-649.
Crossref
Stephen J. Nicholls. (2009) High-Density Lipoprotein and Progression Rate of Atherosclerosis in Intravascular Ultrasound Trials. The American Journal of Cardiology 104:10, pages 16E-21E.
Crossref
Yadong Cui, Douglas J. Watson, Cynthia J. Girman, Deborah R. Shapiro, Antonio M. Gotto, Patricia Hiserote & Michael B. Clearfield. (2009) Effects of Increasing High-Density Lipoprotein Cholesterol and Decreasing Low-Density Lipoprotein Cholesterol on the Incidence of First Acute Coronary Events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). The American Journal of Cardiology 104:6, pages 829-834.
Crossref
Stefania Lamon-Fava, David M. Herrington, David M. Reboussin, Michelle Sherman, Katalin Horvath, Ernst J. Schaefer & Bela F. Asztalos. (2009) Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women. Atherosclerosis 205:1, pages 325-330.
Crossref
A.I. Hatzitolios, V.G. Athyros, A. Karagiannis, C. Savopoulos, C. Charalambous, G. Kyriakidis, Th. Milidis, C. Papathanakis, A. Bitli, I. Vogiatsis, G. Ntaios, N. Katsiki, A. Symeonidis, K. Tziomalos & D.P. Mikhailidis. (2009) Implementation of strategy for the management of overt dyslipidemia: The IMPROVE-dyslipidemia study. International Journal of Cardiology 134:3, pages 322-329.
Crossref
P. -V. Lunoma. (2009) Cytochrome P450 et activation génétique — de la pharmacologie à l’élimination du cholestérol et à la régression de l’athéroscléroseCytochrome P450 and gene activation — from pharmacology to cholesterol elimination and regression of atherosclerosis. Bio tribune magazine 30:1, pages 15-24.
Crossref
Stephen J. Nicholls & Steven E. Nissen. 2009. Clinical Lipidology. Clinical Lipidology 410 419 .
Michael Koutouzis, Kosmas I Paraskevas, Loukianos S Rallidis, Calypso Barbatis, Alexandros Nomikos, Vasiliki Tzavara, Maria Tsopanomichalou, Christos Lioupis, Nikolaos Bessias, Vassilios Andikopoulos, Dimitri P Mikhailidis & Zenon S Kyriakides. (2008) Statin Treatment, Carotid Atherosclerotic Plaque Macrophage Infiltration and Circulating Inflammatory Markers. The Open Cardiovascular Medicine Journal 2:1, pages 110-114.
Crossref
Pauli V. Luoma. (2008) Cytochrome P450 and gene activation—from pharmacology to cholesterol elimination and regression of atherosclerosis. European Journal of Clinical Pharmacology 64:9, pages 841-850.
Crossref
Stephen J Nicholls & E Murat Tuzcu. (2008) High-density lipoprotein and atheroma monitoring. Current Opinion in Cardiology 23:4, pages 386-392.
Crossref
Vasilios G. Athyros, Anna I. Kakafika, Asterios Koragiannis & Dimitri P. Mikhalidis. (2008) Effects of Simvastatin Alone Versus Fenofibrate Alone Versus Simvastatin Plus Fenofibrate on Lipoprotein Subparticle Profiles in Patients With Diabetes Mellitus and Mixed Dyslipidemia. The American Journal of Cardiology 101:11, pages 1679-1680.
Crossref
Maria V. Poulakou, Kosmas I. Paraskevas, Ioannis S. Vlachos, Sonia-Athena P. Karabina, Mark R. Wilson, Dimitrios C. Iliopoulos, Serafim I. Tsitsilonis, Dimitri P. Mikhailidis & Despina N. Perrea. (2008) Effect of Statins on Serum Apolipoprotein J and Paraoxonase-1 Levels in Patients With Ischemic Heart Disease Undergoing Coronary Angiography. Angiology 59:2, pages 137-144.
Crossref
Stefania Lamon-Fava, Margaret R. Diffenderfer, P. Hugh R. Barrett, Aaron Buchsbaum, Nirupa R. Matthan, Alice H. Lichtenstein, Gregory G. Dolnikowski, Katalin Horvath, Bela F. Asztalos, Valeria Zago & Ernst J. Schaefer. (2007) Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism. Journal of Lipid Research 48:8, pages 1746-1753.
Crossref
Gary E. Sander & Thomas D. Giles. (2007) Medical Management of Myocardial Ischemia. The American Journal of Geriatric Cardiology 14:4, pages 205-209.
Crossref
Reijiro ArakawaNorimasa TamehiroTomoko Nishimaki-MogamiKazumitsu UedaShinji Yokoyama. (2005) Fenofibric Acid, an Active Form of Fenofibrate, Increases Apolipoprotein A-I–Mediated High-Density Lipoprotein Biogenesis by Enhancing Transcription of ATP-Binding Cassette Transporter A1 Gene in a Liver X Receptor–Dependent Manner. Arteriosclerosis, Thrombosis, and Vascular Biology 25:6, pages 1193-1197.
Crossref
S SoumianC Albrecht, AH Davies & RGJ Gibbs. (2016) ABCA1 and atherosclerosis. Vascular Medicine 10:2, pages 109-119.
Crossref
Justin C Mason. (2005) The statins - therapeutic diversity in renal disease?. Current Opinion in Nephrology and Hypertension 14:1, pages 17-24.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.